Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-26

Clinical Trial Update: Effect of Liraglutide on Absorption of Paracetamol in Subjects With Type 2 Diabetes [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating whether liraglutide influences the absorption of paracetamol in subjects with Type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Victoza (Liraglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED